Naprosyn Ec (Naproxen)

Naproxen works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which blocks the synthesis of prostaglandins. Lower prostaglandin levels reduce inflammation, pain signaling, and fever, providing the therapeutic effects associated with NSAIDs.

The appropriate dose of Naprosyn Ec is determined by the prescribing healthcare professional based on the specific indication, patient age, weight, renal and hepatic function, and overall risk profile. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Naproxen is generally avoided in the third trimester of pregnancy because of potential fetal cardiovascular risks. Use during earlier trimesters should be considered only if the benefit outweighs the risk and under medical supervision. Limited data are available for breastfeeding; a prescriber should evaluate safety before use.

To order Naprosyn Ec, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Naprosyn Ec (naproxen) has a longer half‑life than ibuprofen, allowing twice‑daily dosing for many patients. Its anti‑inflammatory potency is comparable to diclofenac, while the risk of gastrointestinal irritation is similar across NSAIDs. Choice of agent depends on individual patient risk factors, dosing convenience, and clinician preference.

Naprosyn Ec should be stored at ambient temperature, below 25 °C, in its original packaging to protect from moisture and light. Keep the tablets out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.

Naprosyn Ec is taken orally with a full glass of water. Because it is enteric‑coated, it should be swallowed whole and not crushed or chewed to preserve the coating that reduces gastric irritation. It may be taken with or without food, depending on tolerability.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe skin reactions (e.g., Stevens‑Johnson syndrome), renal impairment, and hypersensitivity reactions including anaphylaxis. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Naprosyn Ec should be avoided in patients with a known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulcer or bleeding, severe heart failure, uncontrolled hypertension, third‑trimester pregnancy, and in individuals taking anticoagulants without close medical supervision.